Inflammation and treatment strategies for suicidal behavior

Area of Science:

• Neuroscience
• Immunology
• Psychiatry

Background:

• Suicide is a significant global health concern.
• Growing evidence implicates immune dysregulation and inflammation in suicidality.
• Understanding these inflammatory mechanisms is crucial for developing effective interventions.

Purpose of the Study:

• To review inflammatory mechanisms associated with suicidal behavior.
• To evaluate emerging therapeutic strategies targeting these pathways.
• To explore precision-based approaches for suicide prevention.

Main Methods:

• Conducted a narrative literature review using keywords like 'suicide,' 'therapy,' 'pharmacotherapy,' and 'inflammation.'
• Searched PubMed and Google Scholar databases.
• Focused on risk factors and interventions for reducing inflammation and suicidal behavior.

Main Results:

• Individuals with suicidal behavior show elevated pro-inflammatory cytokines (e.g., interleukin-6, tumor necrosis factor-α), C-reactive protein, and chemokines.
• Inflammation affects the hypothalamic-pituitary-adrenal axis, monoamine systems, and glutamatergic signaling.
• Neuroinflammation disrupts tryptophan metabolism via indoleamine 2,3-dioxygenase, leading to neurotoxic kynurenine metabolites and reduced serotonin.
• Several immunomodulatory treatments (lithium, ketamine, COX-2 inhibitors, cytokine antagonists, kynurenine-pathway modulators) show potential.

Conclusions:

• Precision-based approaches integrating biomarkers, genetics, and clinical profiles can identify individuals likely to benefit from immunomodulatory therapies.
• Personalized, biologically informed suicide prevention strategies are supported by these findings.
• Targeting inflammation offers a novel avenue for suicide prevention.